SCHEMBL3606815

SCHEMBL3606815

CCOC(=O)c1cnn(Cc2cccc3ccccc23)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.46
LMNA P02545 2/20 0.46
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
KMT2A Q03164 4/20 0.46
MAPK1 P28482 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ALOX15 P16050 2/20 0.46
HCRTR1 O43613 1/20 0.46
TP53 P04637 1/20 0.46
CDC25B P30305 3/20 0.45
GRM2 Q14416 1/20 0.45
EGFR P00533 1/20 0.45
KDR P35968 1/20 0.45
FNTA P49354 1/20 0.43
FNTB P49356 1/20 0.43
CDC25A P30304 1/20 0.43
CDC25C P30307 1/20 0.43
HSP90AB1 P08238 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3096725 0.83 ALDH1A1 (0.56) MAPTLMNAALDH1A1HPGDKMT2A
SCHEMBL3602663 0.82 L3MBTL1 (0.47) LMNAKMT2ASMN1; SMN2HSP90AB1L3MBTL1
SCHEMBL30739039 0.80 GRM2 (0.40) MAPTLMNAALDH1A1HPGDKMT2A
SCHEMBL4767723 0.80 KDM4E (0.49) ALDH1A1KMT2AGRM2KDM4ETDP1
SCHEMBL553848 0.80 ALDH1A1 (0.60) LMNAALDH1A1MAPK1SMN1; SMN2GRM2
SCHEMBL2819485 0.79 KLKB1 (0.55) MAPTLMNAALDH1A1HPGDKMT2A
SCHEMBL30736841 0.78 CRHBP (0.44) MAPTLMNAALDH1A1HPGDKMT2A
SCHEMBL2822906 0.77 ALDH1A1 (0.53) LMNAALDH1A1SMN1; SMN2GRM2L3MBTL1
SCHEMBL16150243 0.77 MEN1 (0.42) MAPTLMNAALDH1A1KMT2ATP53
SCHEMBL20541407 0.76 GRM2 (0.47) LMNAALDH1A1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100041696-A1 Compounds SMITHKLINE BEECHAM CORPORATION 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041696-A1 Compounds CYP11B2, SCD, CYP3A5 MAPT 3377/4885LMNA 1551/4885ALDH1A1 430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.